HydroCision
Health Care
$5.5Mtotal raised · 3 rounds on record
$2.5Mlatest round · Venture round · Nov 2024 · 23 mo ago
$5Mrevenue · 2024 · SEC Form D 0001031309-25-000003
1backers · Omega Funds
Overview
HydroCision helps improve clinical outcomes by adapting its FluidJet technology for spine & orthopedic applications through the SpineJet and TenJet devices.
Key facts
These are the key facts about HydroCision on Alion as of Nov 13, 2026. It has raised $5.5M in 2 funding rounds. The latest round is Venture - Series Unknown of $2.5M, announced in 2024.
- Employees
- 10+Alion company profile, an estimated range
- Total raised
- $5.5MSum of 2 equity rounds Alion knows
- Latest round
- Venture - Series Unknown · $2.5M · Nov 15, 2024SEC Form D filing · sec.gov
Official records
Funding and backers
Total raised
$5.5M
3 rounds on record
Latest round
$2.5M
Venture round · Nov 2024 · 23 mo ago
Team
11-50
employees, estimated range
Grants
$300k
1 grant · CORDIS
Revenue
$5M
2024 · SEC Form D 0001031309-25-000003
Backers
1
Omega Funds
The money's age
Due for its next round
23 months since the last round · not hiring
Momentum
0/100
no fresh signals
Last sign of life
1 mo ago
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Nov 15, 2024
Raised a round Venture round $2.5M · SEC Form D
Apr 1, 2023
Won a grant $300k · CORDIS
Mar 5, 2019
New executive HydroCision Appoints Medical Device Executive with Global Commercial and Market Development Experience as New CEO · markets.businessinsider.com
Mar 9, 2017
Raised a round Venture round $3M · SEC Form D
Aug 2000
Website went live first capture in the Wayback Machine
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Venture round | Nov 2024 | $2.5M | — | SEC Form D |
| Grant | Apr 2023 | $300k | — | CORDIS |
| Venture round | Mar 2017 | $3M | — | SEC Form D |
Registers and programsofficial lists and records that name the company
| Legal entity | HYDROCISION INC | SEC Form D |
Founders and leadersfrom filings, registers and the company's site
Patricia VanblarcomExecutive OfficerSEC Form D
Paul KowalskiExecutive OfficerSEC Form D
Richard Lytle IiiExecutive Officer, DirectorSEC Form D
Thomas AbertExecutive OfficerSEC Form D
Backed byfrom the funds' portfolios and accelerator catalogs
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
AngioInsight improves clinical outcomes by using precise AI diagnosis and optimal management for both coronary artery and microvascular…
Band Connect is an evidence-based hybrid therapy platform for orthopedic rehab that helps providers and their patients improve clinical and…
Accelerating the development of new formulations for hematological diseases designed to:. GreenJay Therapeutics, Inc. (GreenJay) is a…
Windward Bio is a clinical-stage, drug development company committed to improving outcomes for people living with serious immunological…
Simplify 3D surgical case planning with Enhatch – your all-in-one virtual planning solution for 3D printed implants and guides for…
PathKeeper Surgical, Surgical Navigation, Navigated spine surgery.
Financials
Est. Annual Revenue
$3M
2024
Total raised
$5.8M
Latest round
Venture - Series Unknown
Funding rounds
3
Revenue
Estimate
Low-high range
Modelled from public signals, not audited accounts - read it as an order of magnitude.
| Year | Estimate | Low | High |
|---|---|---|---|
| 2016 | $3M | $1M | $5M |
| 2024 | $3M | $1M | $5M |
People
Patricia Vanblarcom
Executive Officer
Paul Kowalski
Executive Officer
Richard Lytle Iii
Executive Officer, Director
Thomas Abert
Executive Officer
Doug Wall
Director
Terry Wall
Director
Yu Xiaotong
Director
Howard Donnelly
Director
Marc Goldberg
Director
Long Zhan
Director
Bryan Grulke
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
Connections
List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors
Omega FundsVia a fund
Click a company to open it. Dashed lines are likely connections. The second step of the network is part of the Pro plan.
Owner
Same company
Same group
Likely
Shared investors
News
Not All Heel Pain is the Same
By Michael Dakkak, DO Dr. Dakkak is a fellowship-trained sports medicine physician practicing at Cleveland Clinic Weston Hospital in Florida. He specializes in non-surgical treatment options for treating orthopedic injuries or chronic pain. Plantar fascio
Read more
Report
TenJet Patient Story: "TenJet gave me renewed optimism"
A Marathon Runner's Hamstring Pain Megan M., a runner from Cleveland, OH, struggled with chronic tendon pain in her hamstrings for over fifteen years. Read this Q&A with Megan to learn about her experience with TenJet. HydroCision: What led you to seek tr
Read more
Report
Understanding Epicondilytis-Elbow Tendinitis or Tendinosis?
By Michael Dakkak, DO Dr. Dakkak is a fellowship-trained sports medicine physician practicing at Cleveland Clinic Weston Hospital in Florida. He specializes in non-surgical treatment options for treating orthopedic injuries or chronic pain. Epicondylitis
Read more
Report
How to cite this page
Alion, "HydroCision: key facts", as of Nov 13, 2026. https://alion.io/company/hydrocision
These figures are published under a free licence. You may reuse them, including commercially, as long as you credit Alion and link back to this page. CC BY-SA 4.0